[{"NetIncomeLoss_1_Q1_USD":-16191000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":22100840.0,"InterestAndOtherIncome_1_Q1_USD":15000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":9716000.0,"InterestPaidNet_1_Q1_USD":429000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-3251000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-623000.0,"Depreciation_1_Q1_USD":300000.0,"GrantsReceivable_0_Q1_USD":1100000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":58775000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8139000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-58000.0,"AssetsCurrent_0_Q1_USD":215393000.0,"LongTermDebt_0_Q1_USD":29498000.0,"ContractWithCustomerLiability_0_Q1_USD":35710000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4950608.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":284000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":662000.0,"CommonStockSharesIssued_0_Q1_shares":23516587.0,"Assets_0_Q1_USD":223842000.0,"ShareBasedCompensation_1_Q1_USD":3821000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3721000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":662000.0,"CommonStockParOrStatedValuePerShare_0_Q1_GBP":0.01,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q1_USD":21886000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":171000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9693000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3733000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":182000.0,"AssetsFairValueDisclosure_0_Q1_USD":0.0,"AccountsReceivableNetCurrent_0_Q1_USD":2000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-340000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":236000.0,"CommonStockValue_0_Q1_USD":300000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":662000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":325000.0,"RevenueFromRelatedParties_1_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":74059000.0,"ProceedsFromIssuanceOfDebt_1_Q1_USD":15000000.0,"DeferredRevenueNoncurrent_0_Q1_USD":25616000.0,"FinancialLiabilitiesFairValueDisclosure_0_Q1_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-16191000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-16249000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-304000.0,"OtherAssetsNoncurrent_0_Q1_USD":2178000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3025000.0,"Cash_0_Q1_USD":195901000.0,"Liabilities_0_Q1_USD":81751000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":1800000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":713000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":662000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":922000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":4198000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-16531000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3821000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13707000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1104000.0,"LiabilitiesCurrent_0_Q1_USD":20806000.0,"DeferredRevenueCurrent_0_Q1_USD":10094000.0,"AccountsPayableCurrent_0_Q1_USD":996000.0,"NonoperatingIncomeExpense_1_Q1_USD":-507000.0,"InterestExpense_1_Q1_USD":522000.0,"CommonStockSharesOutstanding_0_Q1_shares":23516587.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":195901000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":284000.0,"LongTermDebtNoncurrent_0_Q1_USD":29498000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_1_Q1_USD":308000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0793,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":353000.0,"AdditionalPaidInCapital_0_Q1_USD":312793000.0,"NoncurrentAssets_0_Q1_USD":6271000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":0.0,"NumberOfOperatingSegments_1_Q1_segment":2.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2550000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5962000.0,"DeferredFinanceCostsNet_0_Q1_USD":620000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3520000.0,"LeaseCost_1_Q1_USD":312000.0,"CommonStockSharesAuthorized_0_Q1_shares":31995653.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1808000.0,"OperatingIncomeLoss_1_Q1_USD":-16024000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":58775000.0,"OperatingLeaseCost_1_Q1_USD":232000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":223842000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1737000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q1_USD":9614000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3821000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":6748000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":59911000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":708000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-1858000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.73,"ProfitLoss_1_Q1_USD":-16191000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2806000.0,"OtherLiabilitiesCurrent_0_Q1_USD":127000.0,"StockholdersEquity_0_Q1_USD":142091000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":623000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":30000000.0,"VariableLeaseCost_1_Q1_USD":80000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-167751000.0,"OperatingExpenses_1_Q1_USD":17832000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1905000.0,"Ticker":"BCYC","CIK":"1761612","name":"BICYCLE THERAPEUTICS PLC","OfficialName":"Bicycle Therapeutics plc American Depositary Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"738781455.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]